BARCLAYS PLC - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 108 filers reported holding PULMONX CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of PULMONX CORP
ValueSharesWeighting
Q3 2023$960
+83.2%
92,938
+132.7%
0.00%
Q2 2023$524
+170.1%
39,937
+129.5%
0.00%
Q1 2023$194
+145.6%
17,398
+87.4%
0.00%
Q4 2022$79
-99.7%
9,284
+499.0%
0.00%
Q3 2022$26,000
-29.7%
1,550
-39.5%
0.00%
Q2 2022$37,000
-76.4%
2,561
-59.5%
0.00%
Q1 2022$157,0006,3290.00%
Other shareholders
PULMONX CORP shareholders Q1 2023
NameSharesValueWeighting ↓
KPCB XIII Associates, LLC 994,971$10,278,0505.54%
ABG-WTT Global Life Science Capital Partners GP Ltd 60,204$621,9072.98%
PURA VIDA INVESTMENTS, LLC 726,298$7,502,6581.42%
CFM WEALTH PARTNERS LLC 264,039$2,727,5230.71%
BRAIDWELL LP 988,559$10,211,8140.32%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,017,958$10,515,5060.23%
Rock Springs Capital Management LP 652,400$6,739,2920.18%
Point72 Asset Management, L.P. 2,929,903$30,265,8980.09%
ALGERT GLOBAL LLC 117,327$1,2120.06%
Campbell & CO Investment Adviser LLC 45,380$468,7750.06%
View complete list of PULMONX CORP shareholders